Hematologic Oncology Update cover image

Oncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting

Hematologic Oncology Update

00:00

Lusperisps

Lusperisps is being tried in the maloplyphum neoplasms like malofibrosis because of its anti-cytic kind of effect. There are some early reports of it being successful used there, but we'll have to wait and see on more data. Lus perisps has a negative cytokine trap, so it should help that. It's certainly worth doing except for the occasional fatigue, it's well tolerated.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app